Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.610
-0.070 (-2.61%)
Feb 20, 2026, 3:05 PM EST - Market open
Genelux Employees
Genelux had 24 employees as of March 31, 2025. The number of employees increased by 1 or 4.35% compared to the same quarter last year.
Employees
24
Change
1
Growth
4.35%
Revenue / Employee
n/a
Profits / Employee
-$1,328,083
Market Cap
115.58M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 24 | 1 | 4.35% |
| Dec 31, 2024 | 24 | 1 | 4.35% |
| Sep 30, 2024 | 25 | 3 | 13.64% |
| Jun 30, 2024 | 24 | 4 | 20.00% |
| Mar 31, 2024 | 23 | 8 | 53.33% |
| Dec 31, 2023 | 23 | 8 | 53.33% |
| Sep 30, 2023 | 22 | 7 | 46.67% |
| Jun 30, 2023 | 20 | 6 | 42.86% |
| Mar 31, 2023 | 15 | 1 | 7.14% |
| Dec 31, 2022 | 15 | 1 | 7.14% |
| Sep 30, 2022 | 15 | - | - |
| Jun 30, 2022 | 14 | 1 | 7.69% |
| Mar 31, 2022 | 14 | 1 | 7.69% |
| Mar 31, 2021 | 13 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 341 |
| Codexis | 188 |
| Inovio Pharmaceuticals | 134 |
| Seer, Inc. | 134 |
| Fortress Biotech | 101 |
| Immunic | 90 |
| Korro Bio | 87 |
| Cardiff Oncology | 33 |
GNLX News
- 5 weeks ago - Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan Partners - GlobeNewsWire
- 6 weeks ago - Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock - GlobeNewsWire
- 6 weeks ago - Genelux Corporation Announces Proposed Public Offering of Common Stock - GlobeNewsWire
- 7 weeks ago - Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer - GlobeNewsWire
- 3 months ago - Genelux Corporation Reports Third Quarter 2025 Financial Results and Provides General Business Updates - GlobeNewsWire
- 7 months ago - Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates - GlobeNewsWire
- 8 months ago - Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development - GlobeNewsWire
- 10 months ago - Genelux Corporation Reports First Quarter 2025 Financial Results and Provides General Business Updates - GlobeNewsWire